Combine AI-generated tests with intelligent test selection to manage large regression suites and speed up feedback ...

OpenAI wants to retire the leading AI coding benchmark—and the reasons reveal a deeper problem with how the whole industry measures itself.

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

OpenAI and Paradigm launched EVMbench, a tool that tests how capable AI agents are at finding and fixing smart contract vulnerabilities.

Keysight-owned Spirent Communications has launched Luma, an agentic AI solution aimed at augmenting network tests.

Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.